Investigating how sex chromosomes affect brain immune responses in Alzheimer's disease and aging
Sex chromosomal regulation of hippocampal microglial activation with Alzheimer's disease and aging
This study is looking at how differences between male and female brains might affect the immune cells that help fight Alzheimer's disease, with the hope of finding new ways to treat the condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oklahoma Medical Research Foundation NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project ID | NIH-10919230 on NIH RePORTER |
What this research studies
This research explores the role of sex chromosomes in the activation of microglia, the immune cells in the brain, as it relates to Alzheimer's disease (AD) and aging. It aims to understand how these biological differences between sexes may influence the progression and severity of AD. By studying transgenic mouse models, the research will examine the mechanisms behind sex-biased responses to AD pathology, focusing on how microglial behavior differs in males and females. The ultimate goal is to identify new therapeutic targets that could lead to better treatments for AD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for Alzheimer's disease, particularly those with a family history or genetic predispositions related to sex differences.
Not a fit: Patients who do not have a risk for Alzheimer's disease or those with other forms of dementia unrelated to the mechanisms being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for Alzheimer's disease that take into account the biological differences between sexes.
How similar studies have performed: While the specific focus on sex chromosomal regulation in microglial activation is relatively novel, there have been successful studies exploring sex differences in Alzheimer's disease and microglial function.
Where this research is happening
Oklahoma City, United States
- Oklahoma Medical Research Foundation — Oklahoma City, United States (Active)
Researchers
- Principal investigator: Ocanas, Sarah Renee — Oklahoma Medical Research Foundation
- Study coordinator: Ocanas, Sarah Renee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.